13F-HR filed by Soleus Capital Management, L.P.
Soleus Capital Management, L.P. filed this 13F-HR for the quarter ended 2021-06-30, filed 2021-08-16, with 65 holding rows worth $650,274,000.
- Accession
- 0001802630-21-000011
- Filer
- CIK 1802630
- Filed
- 2021-08-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2021
A holdings report, 65 entries on the cover page, a total value of $650,274,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $650,276,000 with VALUE read as thousands by filing date, 13F file number 028-20043. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| BIOATLA INC | 09077B104 | COM | 2,794,233 | $118,420,000 | thousands by filing date | |
| ESSA PHARMA INC | 29668H708 | COM NEW | 2,238,104 | $63,943,000 | thousands by filing date | |
| C4 THERAPEUTICS INC | 12529R107 | COM STK | 870,758 | $32,949,000 | thousands by filing date | |
| NEUROPACE INC | 641288105 | COMMON STOCK | 1,384,387 | $32,935,000 | thousands by filing date | |
| THERATECHNOLOGIES INC COM | 88338H100 | COM | 7,028,096 | $27,269,000 | thousands by filing date | |
| LANTHEUS HLDGS INC | 516544103 | COM | 913,697 | $25,255,000 | thousands by filing date | |
| NOVOCURE LTD | G6674U108 | ORD SHS | 98,975 | $21,955,000 | thousands by filing date | |
| EDAP TMS S A | 268311107 | SPONSORED ADR | 2,576,401 | $18,267,000 | thousands by filing date | |
| IVERIC BIO INC | 46583P102 | COM | 2,808,343 | $17,721,000 | thousands by filing date | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 103,114 | $16,693,000 | thousands by filing date | |
| NEOGENOMICS INC | 64049M209 | COM NEW | 352,007 | $15,900,000 | thousands by filing date | |
| SKINHEALTH SYSTEMS INC | 88331L108 | COM CL A | 934,316 | $15,697,000 | thousands by filing date | |
| Surmodics Inc | 868873100 | Common Stock | 278,404 | $15,103,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 250,146 | $14,984,000 | thousands by filing date | |
| IRADIMED CORP | 46266A109 | COMMON STOCK | 497,179 | $14,622,000 | thousands by filing date | |
| ITAMAR MED LTD SPONSORED ADS | 465437101 | ADR | 530,839 | $12,501,000 | thousands by filing date | |
| CVRX INC | 126638105 | COMMON STOCK | 426,394 | $11,939,000 | thousands by filing date | |
| SIENTRA INC | 82621J105 | COM | 1,461,563 | $11,634,000 | thousands by filing date | |
| NATERA INC COM | 632307104 | Stock | 101,839 | $11,562,000 | thousands by filing date | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 563,396 | $9,826,000 | thousands by filing date | |
| GOSSAMER BIO INC | 38341PAA0 | NOTE 5.000% 6/0 | 10,700,000 | $8,596,000 | thousands by filing date | principal |
| VAXCYTE INC COM | 92243G108 | Stock | 375,650 | $8,456,000 | thousands by filing date | |
| EVOLUS INC | 30052C107 | COM | 580,000 | $7,337,000 | thousands by filing date | |
| INHIBRX INC | 45720L107 | COM | 242,789 | $6,682,000 | thousands by filing date | |
| EDITAS MEDICINE INC | 28106W103 | COM | 95,600 | $5,415,000 | thousands by filing date | |
| CUTERA INC | 232109108 | COM | 102,980 | $5,049,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 144,300 | $4,877,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 127,743 | $4,873,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 67,529 | $4,592,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,122,000 | $4,353,000 | thousands by filing date | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 233,697 | $4,351,000 | thousands by filing date | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 21,550 | $4,165,000 | thousands by filing date | |
| MIMEDX GROUP INC | 602496101 | COM | 322,160 | $4,030,000 | thousands by filing date | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 125,700 | $3,990,000 | thousands by filing date | |
| CELCUITY INC | 15102K100 | COM | 164,824 | $3,956,000 | thousands by filing date | |
| PULMONX CORP | 745848101 | COM | 85,250 | $3,761,000 | thousands by filing date | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 178,360 | $3,753,000 | thousands by filing date | |
| AXOGEN INC | 05463X106 | COM | 158,140 | $3,417,000 | thousands by filing date | |
| ARYA SCIENCES ACQU CORP IV | G31659108 | COM | 300,000 | $3,216,000 | thousands by filing date | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 1,950,000 | $3,201,000 | thousands by filing date | principal |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 22,100 | $2,844,000 | thousands by filing date | |
| GALECTO INC | 36322Q107 | COM | 538,152 | $2,723,000 | thousands by filing date | |
| ALPHA TEKNOVA INC | 02080L102 | COMMON STOCK | 114,546 | $2,718,000 | thousands by filing date | |
| CAREDX INC | 14167L103 | COM | 29,300 | $2,682,000 | thousands by filing date | |
| DEXCOM INC COM | 252131107 | Stock | 5,884 | $2,512,000 | thousands by filing date | |
| INSULET CORP COM | 45784P101 | Stock | 8,980 | $2,465,000 | thousands by filing date | |
| 4D MOLECULAR THERAPEUTICS INC COM | 35104E100 | Stock | 100,800 | $2,427,000 | thousands by filing date | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 26,568 | $2,320,000 | thousands by filing date | |
| Misonix Inc | 604871103 | COM | 100,788 | $2,235,000 | thousands by filing date | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 17,500 | $2,173,000 | thousands by filing date | |
| HALOZYME THERAPEUTICS INC COM | 40637H109 | Stock | 44,100 | $2,003,000 | thousands by filing date | |
| Rafael Holdings Inc Class B | 75062E106 | COM | 36,742 | $1,876,000 | thousands by filing date | |
| EIGER BIOPHARMACEUTICALS INC | 28249U105 | COM | 213,519 | $1,819,000 | thousands by filing date | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 75,000 | $1,703,000 | thousands by filing date | |
| CATABASIS PHARMACEUTICALS IN | 14875P206 | COM NEW | 775,000 | $1,635,000 | thousands by filing date | |
| CAREMAX INC | 14171W103 | COM | 118,900 | $1,534,000 | thousands by filing date | |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 183,076 | $1,470,000 | thousands by filing date | |
| Renalytix PLC | 75973T101 | ADS | 47,300 | $1,460,000 | thousands by filing date | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 31,306 | $967,000 | thousands by filing date | |
| DIANTHUS THERAPEUTICS INC COM | 55910K108 | Stock | 90,000 | $880,000 | thousands by filing date | |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 47,537 | $780,000 | thousands by filing date | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 31,300 | $668,000 | thousands by filing date | |
| INARI MED INC | 45332Y109 | COM | 6,150 | $574,000 | thousands by filing date | |
| KADMON HLDGS INC | 48283N106 | COM | 86,442 | $335,000 | thousands by filing date | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 7,300 | $228,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001802630-21-000011 | this filing | 2021-08-16 | acceptance time not in the bulk data set |